The global contract development and manufacturing organization is investing $1.2 billion to boost production capabilities at ...
After a years-long antitrust battle, the European Commission on Friday approved Illumina’s plans to divest Grail. However, ...
The FDA on Thursday approved the label expansion of AstraZeneca’s Fasenra as an add-on maintenance treatment for severe ...
Florida District Judge Roy Altman earlier this week ruled against Eli Lilly, finding that the drugmaker cannot use state law ...
The European Medicines Agency on Friday said it found no evidence linking GLP-1 receptor agonists with suicidal thoughts and actions, following a review of patients taking Novo Nordisk’s semaglutide ...
Data presented at the American Association for Cancer Research’s annual meeting sparked hope that we could be getting closer ...
Vertex Pharmaceuticals on Wednesday announced it is acquiring clinical-stage immunotherapy company Alpine Immune Sciences for ...
The U.S. Department of Justice has filed a complaint against Regeneron alleging that the pharma knowingly omitted credit card ...
Novartis on Thursday announced that it is making $150 million in upfront payments to protein degradation biotech Arvinas, ...
This week’s American Association for Cancer Research annual meeting drove home the importance of antibody-drug conjugates as ...
A new Scandinavian study published Wednesday found no conclusive evidence to support the link between GLP-1 receptor agonists ...
Less than half of cancer drugs approved via the FDA's accelerated approval pathway between 2013 and 2017 showed clinical ...